Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Walls

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Basic & Clinical Pharmacology & Toxicology|February 25, 2024
Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classificationMorten Baltzer Houlind, Luise Hansen, Esben Iversen, et al.
Bioorganic & Medicinal Chemistry Letters|January 3, 2012
Fatty acid amide hydrolase inhibitors. 3: tetra-substituted azetidine ureas with in vivo activityStephen D Roughley, Helen Browne, Alba T Macias, et al.
JAMA Network Open|July 25, 2025
Adherence to Quality-of-Care Indicators and Mortality Outcomes in Patients With MRSA Bacteremia: A Post Hoc Analysis of the CAMERA2 Randomized Clinical TrialI Russel Lee, Yanan Zhu, Neela J Rai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2024
Management, Outcomes, and Predictors of Mortality of Cryptococcus Infection in Patients Without HIV: A Multicenter Study in 46 Hospitals in Australia and New ZealandJulien Coussement, Christopher H Heath, Matthew B Roberts, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 26, 2023
Current Epidemiology and Clinical Features of Cryptococcus Infection in Patients Without Human Immunodeficiency Virus: A Multicenter Study in 46 Hospitals in Australia and New ZealandJulien Coussement, Christopher H Heath, Matthew B Roberts, et al.
JAMA|February 12, 2020
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical TrialSteven Y C Tong, David C Lye, Dafna Yahav, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Basic & Clinical Pharmacology & Toxicology|February 25, 2024
Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classificationMorten Baltzer Houlind, Luise Hansen, Esben Iversen, et al.
Bioorganic & Medicinal Chemistry Letters|January 3, 2012
Fatty acid amide hydrolase inhibitors. 3: tetra-substituted azetidine ureas with in vivo activityStephen D Roughley, Helen Browne, Alba T Macias, et al.
JAMA Network Open|July 25, 2025
Adherence to Quality-of-Care Indicators and Mortality Outcomes in Patients With MRSA Bacteremia: A Post Hoc Analysis of the CAMERA2 Randomized Clinical TrialI Russel Lee, Yanan Zhu, Neela J Rai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2024
Management, Outcomes, and Predictors of Mortality of Cryptococcus Infection in Patients Without HIV: A Multicenter Study in 46 Hospitals in Australia and New ZealandJulien Coussement, Christopher H Heath, Matthew B Roberts, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 26, 2023
Current Epidemiology and Clinical Features of Cryptococcus Infection in Patients Without Human Immunodeficiency Virus: A Multicenter Study in 46 Hospitals in Australia and New ZealandJulien Coussement, Christopher H Heath, Matthew B Roberts, et al.
JAMA|February 12, 2020
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical TrialSteven Y C Tong, David C Lye, Dafna Yahav, et al.
Pageof 6